Topics
Pediatric CNS tumors | Treatment | Targeted therapy | Tovorafenib
Home > Publications > Topics > Pediatric CNS tumors > Treatment > Targeted therapy > Tovorafenib
Reynolds S.
Tovorafenib Approved for
Some Children with Low-Grade Glioma.
Cancer
Curr Blog. 2024 May 28. News. ˍ
Singh S, Bradford D, Chatterjee S, Li X, Aungst SL, Skinner AM,
Miller CP, Kim-McOlash S, Fourie Zirkelbach J, Xiong Y, Bi Y, Wang
YH, Yang Y, Sun J, Kraft J, Charlab R, Shord SS, Tang S, Scepura
B, Bulatao I, Udoka O, Saber H, Rahman NA, Pazdur R, Singh H,
Donoghue M, Drezner N.
FDA Approval
Summary: Tovorafenib for
Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma.
Clin
Cancer Res.
2025 Jan 14. doi:
10.1158/1078-0432.CCR-24-3439. PMID:
39808502. Drug updates˰
ˍ